Kwon, H.; Yun, M.; Kwon, T.-H.; Bang, M.; Lee, J.; Lee, Y.S.; Ko, H.Y.; Chong, K.
Fibronectin Type III Domain Containing 3B as a Potential Prognostic and Therapeutic Biomarker for Glioblastoma. Biomedicines 2023, 11, 3168.
https://doi.org/10.3390/biomedicines11123168
AMA Style
Kwon H, Yun M, Kwon T-H, Bang M, Lee J, Lee YS, Ko HY, Chong K.
Fibronectin Type III Domain Containing 3B as a Potential Prognostic and Therapeutic Biomarker for Glioblastoma. Biomedicines. 2023; 11(12):3168.
https://doi.org/10.3390/biomedicines11123168
Chicago/Turabian Style
Kwon, Hyukjun, Minji Yun, Taek-Hyun Kwon, Minji Bang, Jungsul Lee, Yeo Song Lee, Hae Young Ko, and Kyuha Chong.
2023. "Fibronectin Type III Domain Containing 3B as a Potential Prognostic and Therapeutic Biomarker for Glioblastoma" Biomedicines 11, no. 12: 3168.
https://doi.org/10.3390/biomedicines11123168
APA Style
Kwon, H., Yun, M., Kwon, T.-H., Bang, M., Lee, J., Lee, Y. S., Ko, H. Y., & Chong, K.
(2023). Fibronectin Type III Domain Containing 3B as a Potential Prognostic and Therapeutic Biomarker for Glioblastoma. Biomedicines, 11(12), 3168.
https://doi.org/10.3390/biomedicines11123168